We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Cannabis & Psychedelics News

Nevada Regulators Approve Cannabis Consumption Lounges

The first lounges are expected to open later in the year.

Read More

Pesticide Testing is Now Compulsory for Rhode Island-Grown Cannabis

From today, June 30, all cannabis harvested in the northeastern state must undergo pesticide testing at a cannabis lab.

Read More

Cannabis Consumers Have Lower Rates of Liver Cancer, Study Finds

Frequent cannabis consumers are less likely to develop a form of liver cancer than their cannabis-sober counterparts, according to a new study.

Read More

Three Cannabis Cultivators Fined $209k for River Pollution in California

Three cannabis cultivators are facing a $209,687 fine for discharging sediment into a northern Californian river.

Read More

UK Government Urged to Do More for Cannabinoid Industry in New Report

The UK’s CBD industry is “hamstrung” by poor regulation, according to a new report.

Read More

Harvest Hemp Early for Maximum CBD, Scientists Say

Hemp cultivators should harvest their plants before they reach full seed maturity if they want to maximize the amount of CBD that can be extracted, a new study published in Royal Society Open Science suggests.

Read More

Dalton Receives Approval for Cannabis Analytical Test Licence

This licence is in addition to their previously held CDL and SPL, allowing Dalton to perform analytical tests related to our ability to develop cannabis products for our clients.

Read More

Some State Licensing Approaches Can Fuel the Illicit Cannabis Market

As long as cannabis remains federally illegal and licensing remains the responsibility of states, each state may continue to act based on their own estimation of the trade-offs involved, which can carry negative externalities for other.

Read More

Canadian Company Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics

The move would enable the Company to synthesize, process and distribute pharmaceutical grade 3,4-Methylenedioxymethamphetamine (“MDMA”), among other substances, at its Princeton, British Columbia facility.

Read More

 
Advertisement